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Abstract
Although exposure to ionizing radiation (IR) can produce significant neurotoxicity, the
mechanisms mediating this toxicity remain to be determined. Previous studies using neurons
isolated from the central nervous system show that IR produces reactive oxygen species and
oxidative DNA damage in those cells. Because the base excision DNA repair pathway repairs
single-base modifications caused by ROS, we asked whether manipulating this pathway by
altering APE1 expression would affect radiation-induced neurotoxicity. In cultures of adult
hippocampal and sensory neurons, IR produces DNA damage as measured by phosphorylation of
histone H2A.X and results in dose-dependent cell death. In isolated sensory neurons, we
demonstrate for the first time that radiation decreases the capsaicin-evoked release of the
neuropeptide CGRP. Reducing APE1 expression in cultured cells augments IR-induced
neurotoxicity, whereas overexpressing APE1 is neuroprotective. Using lentiviral constructs with a
neuronal specific promoter that selectively expresses APE1’s different functions in neurons, we
show that selective expression of the DNA repair competent (redox inactive) APE1 constructs in
sensory neurons resurrects cell survival and neuronal function, whereas use of DNA-repair
deficient (redox active) constructs is not protective. Use of an APE1 redox-specific inhibitor,
APX3330, also facilitates neuronal protection against IR-induced toxicity. These results
demonstrate for the first time that the repair function of APE1 is required to protect both
hippocampal and DRG neuronal cultures—specifically neuronal cells—from IR-induced damage,
while the redox activity of APE1 does not appear to be involved.
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1. Introduction
Ionizing radiation (IR) could affect the central nervous system (CNS) secondary to actions
on non-neuronal targets such as disruption of the blood-brain barrier [1] or could have direct
cytotoxic consequences to neurons [2, 3] and/or neurogenesis [4, 5]. Ionizing radiation (IR)
can produce significant neurotoxicity, especially upon direct exposure to central nervous
system tissues [6, 7]. Toxicities can range from fatigue to cognitive dysfunction [6, 8]. With
high exposure, cell loss can occur in the brain and spinal cord [7].
Although many IR neurotoxicity studies focus on the CNS, the question remains whether
radiation also causes significant toxicity to peripheral neurons (autonomic, motor, or sensory
neurons). In the GI tract and bladder, IR alters levels of substance P and calcitonin gene-
related peptide (CGRP), two neuropeptides found in small-diameter sensory neurons [9–11].
These peptides modulate intestinal injury after radiation: CGRP is protective, while SP
contributes to the pathophysiology [12] in the gut, worsening early-onset radiation-induced
toxicity [12]. Thus, radiation might directly affect sensory neurons, exacerbating radiation-
induced injury in various organs.
The mechanisms by which IR produces neurotoxicity are undetermined. Using cultured
neurons isolated from the central nervous system, several investigators have shown that IR
exposure causes a dose-dependent increase in the production of reactive oxygen species
(ROS) [13], increase in in DNA damage [13, 14], and apoptosis [13, 15]. Thus, it is
plausible that, in situ, radiation-induced oxidative damage to DNA can subsequently alter
neuronal function and cause cell death.
The base excision repair (BER) pathway is the main vehicle for repairing oxidative damage
to DNA. It also has a prominent role in nondividing tissues [16–19]. A key component of
BER, human apurinic/apyrimidinic (AP) endonuclease (APE1), is required for repair of
single-base modifications, such as those caused by reactive ROS [16–19], including IR-
induced ROS [20–22]. APE1 also functions as a major reduction-oxidation (redox) factor,
which influences transcriptional regulation of gene expression [19, 20].
Because IR increases ROS and DNA damage in neurons [16, 17, 22], we asked whether
modulating APE1’s expression could alter IR-induced neurotoxicity. As endpoints, we
measured cell death, DNA damage, and IR’s ability to decrease the stimulated release of the
neurotransmitter CGRP from sensory neurons. We demonstrated that APE1 is involved in
protecting dorsal root ganglion (DRG) cells from IR’s killing effects and its ability to cause
neuronal dysfunction. Using mutated APE1 proteins, we showed that the neuroprotective
effect is mediated by APE1’s repair function. Additionally, a small-molecule inhibitor that
blocks APE1’s redox function also enhances the molecule’s neuroprotective ability, but only
in the presence of native APE1 and not with overexpression of an APE1 mutant with only
redox activity. This latter finding suggests that blocking APE1 redox function can augment
repair. Furthermore, these findings have important translational implications: using a small
molecule to block IR’s deleterious effects during IR therapy would heighten the quality of
life of cancer survivors [6, 23, 24].
2. Materials and Methods
2.1 Materials
Tissue culture supplies were obtained from Invitrogen (Carlsbad, CA). Normocin came from
InvivoGen (San Diego, CA). Nerve growth factor was purchased from Harlan Bioproducts
for Science, Inc. (Indianapolis, IN). Poly-D-lysine, laminin, peripherin monoclonal
antibodies, and routine chemicals came from Sigma-Aldrich Inc. (St. Louis, MO). Optiprep
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was obtained from NYCOMED PHARMA AS (Oslo, Norway). Neuroporter® (transfecting
agent) was purchased from Gene Therapy Systems (San Diego, CA). Mouse monoclonal
antihuman APE1 antibodies came from Novus Biologicals (Littleton, CO); anti-phospho-
H2A.X antibodies were from Upstate Cell Signaling Solutions (Charlottesville, VA). Goat
anti-mouse HRP conjugated IgG secondary antibody was from Zymed Laboratories Inc.
(San Francisco, CA); actin antibodies were purchased from Thermo (Fremont CA). HA rat
monoclonal antibodies were from Roche Applied Science (Mannhiem, Germany). Cy3-
conjugated donkey anti-mouse IgG antibody, biotin-conjugated donkey anti-rabbit IgG, and
Cy3-conjugated streptavidin were from Jackson ImmunoResearch (West Grove, PA).
APX3330 was synthesized as previously described [25, 26]. The Animal Care and Use
Committee at Indiana University School of Medicine, Indianapolis, IN, approved all
procedures used in these studies.
2.2 Cell Cultures
Neuronal cultures were prepared from adult male (150–175 g) Sprague-Dawley rats (Harlan,
Indianapolis, IN) as previously described [27, 28]. Briefly, hippocampal cells were
dissociated using papain and mechanical agitation and separated by gradient centrifugation.
The pellet of cells from a discontinuous gradient of Optiprep in L-15 media was washed
then resuspended in 1ml of growth media consisting of Neurobasal Medium supplemented
with 0.5 mM L-glutamine, 2% B-27 Supplement minus AO, 50 mg/ml Penicillin-
Streptomycin, and 5 ng/ml of Basic Fibroblast Growth Factor (BFGF). Approximately
60,000 cells were plated onto poly-D-lysine and laminin coated plates and grown for 6–14
days in 5% CO2 at 37°C. Growth medium was changed every other day. For sensory
neuronal culture, cells were dissociated using collagenase and mechanical dissociation.
Approximately 30,000 DRG cells were plated into each well of 12- well culture plates or
onto Lab-Tek chamber slides all precoated with poly-D-lysine and laminin. The sensory
neurons were maintained in F-12 media supplemented with 10% horse serum, 2 mM
glutamine, 100μg/ml normocin, 50 μg/ml penicillin, 50 μg/ml streptomycin, 50 μM 5-
fluoro-2′-deoxyuridine, 150 μM uridine, and 30 ng/ml NGF in 3% CO2 at 37°C. Growth
medium was changed every other day, and the cells were used after 11–13 days of culture.
2.3 Assay Methods
Sensory neuronal cultures grown on Lab-Tek microscope chamber slides were processed for
immunofluorescence as previously published using a peripherin antibody (1:500) and HA
antibody (1:500) [29]. Images were collected in red (peripherin), green (HA), and bright-
field modes. A Zeiss LSM offline browser (R4.0: Carl Zeiss Inc.; Thornwood, NY) was
used to determine co-localization of peripherin and HA. For trypan blue exculsion, equal
volumes of 0.4% (w/v) Trypan blue to cell suspension were combined, mixed and scored
under a phase contrast microscope. Dead cells were those that took up the trypan blue and
stain blue, whereas the live cells had yellow nuclei.
For release studies, the sensory neuronal cultures were washed once with HEPES buffer
consisting of (in mM) 25 HEPES, 135 NaCl, 3.5 KCl, 2.5 CaCl2, 1 MgCl2, 3.3 D-glucose,
and 0.1% bovine serum albumin, pH 7.4 and maintained at 37°C. They were then incubated
for successive 10 min intervals with 0.4 ml of HEPES buffer alone (to measure resting
release), with buffer containing 30 nM capsaicin (to measure stimulated release), then with
buffer alone (to measure recovery). After each incubation, the buffer was removed and the
amount of CGRP in each sample was measured using radioimmunoassay as previously
described [30]. After the release experiment, the cells in each well were scraped and
sonicated in 0.4 M HCl and an aliquot taken to measure total CGRP content in the cultures
using radioimmunoassay. Total content was calculated by adding the total amount released
in all incubations to the amount measured in the cells. The release data was calculated as
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fmol released/well/10 min or as a % of the total peptide content in the cells [30]. Western
blot analysis was performed as described previously [17, 28].
Neurons were transfected with siRNA to APE1 (APE1siRNA), or scramble siRNA
(SCsiRNA) and were used as previously described [28].
2.4 Development of Viral Constructs
Adenoviral constructs containing 1) the CMV promoter, HA-tagged APE1, IRES, and
enhanced green fluorescent protein (EGFP); or 2) CMV, IRES, and EGFP were developed
as previously described [28]. DNA sequencing confirmed the constructs in the pLenti6-
R4R2-V5 plasmid containing α CaM kinase II promoter (WT-, C65-, or 226+177-) APE1-
IRES-EGFP. For adenoviral infection, adult neuronal cells were cultured as described in the
absence or presence of siRNA treatment for 7 days, then exposed to adenoviruses (Ad5-
IRES-eGFP and Ad5-HA-APE1-IRES-eGFP) at 30 pfu/cell for hippocampal cultures and
150 pfu/cell for sensory neuronal cultures. After 2 days, the virus was removed then cells
were grown in normal media. For lentiviral infections, DRG cells were cultured 5 days
before 150 pfu/cell of the lentivirus was added to the media. Two days later, the virus was
removed; then cells were grown an additional 5 days in regular media. We previously
demonstrated that APE1’s repair function is neuroprotective against oxidative DNA damage
in hippocampal and sensory neuronal cultures [28]. In those studies and in the current work,
we selectively reduced APE1 expression in the neuronal cultures with with siRNA to rat
APE! mRNA and added back human APE1 transgenes that are not affected by the rat siRNA
since the human APE1 homolog has a different nucleic acid sequence at the binding site
[28].
2.5 Ionizing Radiation Treatment
Cell cultures were irradiated using a Gammacell 40 Exactor Irradiator (Nordion
International Inc). On the first day that the cells were exposed to IR, the media was changed
and the culture plates transported to the irradiator at room temperature. Exposure times vary
with dosing since the machine delivers 10 Gy/~16 min. In all experiments, control cultures
were transported to the irradiator and kept in the room for the same time but not exposed to
IR.
2.6 Data Analysis
Data were expressed as the mean ± the standard error of the mean (SEM) for at least 3
independent experiments from separate harvests. Statistical significance between groups (p
< 0.05) was determined using ANOVA followed by the Tukey post-hoc test.
3. Results
3.1 Reducing APE1 expression augments radiation-induced neuronal cell death
We first confirmed findings of previous studies showing that IR produces oxidative DNA
damage and apoptosis in neurons [31]. When we exposed neuronal cultures to increasing
doses of radiation and examined viability 24 h later using trypan blue exclusion, we
observed a dose-dependent cytotoxicity in sensory neuronal cultures and hippocampal
cultures (Figures 1A, 1B). Survival of sensory neuronal cells cultured in media alone was 97
± 2% after a 3-Gy dose and 83 ± 2% after a 10-Gy dose, respectively. After exposure to a
60-Gy dose, only 32 ± 3% of cells survived. Exposing hippocampal cultures to a 3- or 10-
Gy dose resulted in 92 ± 2 % and 69 ±1% of cells excluding trypan blue, respectively; a 30-
Gy dose reduced viability to 41 ± 2%.
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We next determined whether reducing APE1 expression in the cultures would alter IR’s
toxic effects. Exposing neuronal cultures to SCsiRNA did not significantly alter the number
of cells that excluded trypan blue in response to IR, compared to cells treated with medium
alone (Figures 1A, 1B). In contrast, sensory and hippocampal cultures treated with
APE1siRNA demonstrated enhanced cell death after IR. A 10-Gy dose of radiation
significantly reduced cell viability from 83 ± 2% to 64 ± 2% in sensory neuronal cultures
and from 69 ±1% to 46 ±1% in hippocampal cultures. Reduced APE1 expression resulted in
survival of only 10 ± 1% of sensory neurons 24 h after exposure to a 60-Gy dose and 8 ± 2%
of hippocampal cells after exposure to a 30-Gy dose. APE1 siRNA reduced hippocampal
APE1 levels to 5 ± 5% of the level of control SCsiRNA; APE1 siRNA also reduced APE1 to
15 ± 3% in sensory neuronal cultures compared to cultures treated with SCsiRNA (Figures
1C and 1D). Scramble siRNA did not significantly alter APE1 expression compared to
untreated cultures (data not shown).
3.2 Overexpressing APE1 in neuronal cultures protects against radiation-induced cell
death
Because reducing APE1 expression in neuronal cultures enhances radiation-induced cell
death, we next determined whether overexpressing APE1 could be neuroprotective.
Adenoviral constructs containing the CMV promoter, WT-APE1, IRES, and EGFP were
used to infect sensory and hippocampal cultures pretreated with either SCsiRNA or
APE1siRNA. Cells were exposed to siRNAs on Days 3–5, to virus on Day 7 (for 48 h), to
IR on Day 11, and trypan exclusion measured 24 h after radiation. An adenoviral vector
containing the EGFP construct was used as a control. Western blot analysis was performed
on all cultures using an HA-antibody (data not shown) [28].
Overexpressing APE1 in neuronal cultures significantly attenuated IR’s ability to cause cell
death (Figures 1A and 1B). For example, when sensory neurons treated with SCsiRNA were
exposed to a 60-Gy dose of radiation, only 34 ± 2% of cells were viable after 24 h, but
overexpressing APE1 after radiation increased cell viability to 69 ± 4%. In radiated cells
where APE1 expression was reduced with siRNA treatment, the “add-back” of APE1 via
adenoviral infection increased viability from 10 ± 1% to 53 ± 4%. Analogous results were
observed in hippocampal cultures: 30 Gy of radiation reduced cell viability to 43 ± 2% and 8
± 2% in SCsiRNA and APE1siRNA treated cells, respectively. Overexpressing APE1
increased viability to 66 ± 5 % in cultures treated with SCsiRNA and to 49 ± 2% in cells
treated with APE1siRNA. Therefore, APE1 overexpression is neuroprotective in cells with
reduced or normal complements of APE1. In the absence of IR, reducing or overexpressing
APE1 did not alter cell viability (Figures 1A, 1B). Infection with the viral vector control did
not significantly alter cell viability after radiation in cells treated with either SCsiRNA or
APE1siRNA (not shown).
3.3 Effect of APE1 on DNA damage induced by ionizing radiation
To assess DNA double-strand breaks after IR, we measured histone H2A.X phosphorylation
[32]. Neuronal cultures in the absence or presence of APE1 manipulations were exposed to
significant but not maximal doses of IR that would affect cell viability: 30 Gy for sensory
cells and 15 Gy for hippocampal cells (See Figure 1). Histone H2A.X phosphorylation was
measured using Western blotting 0.5–3 h after IR exposure. In these experiments,
pretreating cultures with APE1siRNA for 48 h significantly reduced the APE1 level to 15 ±
8% of the control sensory neuronal cultures and 10 ± 12% of the control in hippocampal
cultures; SCsiRNA did not significantly alter APE1 levels.
The representative Western blot in Figure 2A and the summary data from 3 experiments in
Figure 2B illustrate that irradiating sensory neuronal cultures treated with SCsiRNA (100
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nM) increased the amount of phospho-H2A.X. However, reducing APE1 expression via
APE1siRNA (100 nM) significantly increased H2A.X phosphorylation. Three h after
radiation, the density of the phospho-H2A.X band (normalized to actin) in cultures exposed
to SCsiRNA was 2.8 ± 1.0, whereas the band in cells exposed to APE1siRNA was 12 ± 0.9.
Similar results were observed in hippocampal cultures (Figure 3). Irradiating hippocampal
cultures treated with SCsiRNA significantly increased the amount of phospho-H2A.X 30
and 60 min afterward and this was further increased by APE1 knockdown (Figure 3A;
summary data in Figure 3B). These results demonstrate that neuronal cultures with reduced
APE1 expression have increased double-strand breaks after IR treatment, as evidenced by
H2A.X phosphorylation.
Additional experiments were performed to overexpress APE1 in the neuronal cultures to
determine if adding APE1 back into the cells provides protection against radiation-induced
DNA damage. Exposure to the viral vector for 48 h two days after SCsiRNA or
APE1siRNA increased H2A.X phosphorylation in a manner analogous to controls. Three h
after radiation, the density of the phosphor-H2A.X band (normalized to actin) in sensory
neuronal cultures exposed to SCsiRNA and adenoviral vector was 1.8 ± 0.6, whereas the
band in cells exposed to APE1siRNA and vector was 10 ± 0.9 (Figure 2B, middle panel).
For hippocampal cultures, 60 min after a 15-Gy dose of radiation the density of the
phospho-H2A.X band (normalized to actin) in cultures exposed to SCsiRNA and adenoviral
vector was 3.9 ± 1.6, whereas the band in cells exposed to APE1siRNA and vector was 11 ±
1.9.
Exposing neuronal cultures to an adenovirus containing WT APE1 dramatically attenuated
the radiation-induced increase in phospho-H2A.X (Figures 2B, 3B). In sensory neuronal
cultures exposed to APE1siRNA then Ad5-APE1, the density of phospho-H2A.X
normalized to actin was 0.9 ± 0.6 and 0.7 ± 0.3 at 1 and 3 h after radiation, respectively. In
hippocampal cultures exposed to APE1siRNA then Ad5-APE1, the density of phospho-
H2A.X normalized to actin was 1.3 ± 0.4 and 0.2 ± 0.1 at 30 and 60 min after radiation,
respectively. These results, taken with the cell viability data in Figure 1, support the notion
that reduced APE1 expression in primary neuronal cultures augments IR cytotoxicity, while
adding back the missing APE1 protein restores survival and reduces double-strand breaks,
demonstrating that APE1 is intrinsically involved in neuronal cell survival.
3.4 Overexpressing APE1 using a neuronal-specific promoter protects sensory neurons
against IR-induced cell death
Although the aforementioned studies demonstrate that APE1 overexpression in neuronal
cultures is neuroprotective, the use of adenoviral constructs with a CMV promoter does not
reveal if APE1’s effects are in neurons themselves or in non-neuronal cells. To examine
whether APE1 overexpression that is restricted to neurons is protective, we developed
lentiviral constructs using a neuronal-specific promoter for α CaM kinase II [33]. Initially,
we ascertained whether the expression of WT-APE1 would be restricted to neurons in
culture using immunohistochemistry. We used double staining with neuronal markers
peripherin [34] and HA-tagged APE1. Figure 4A shows that exposing sensory neurons to
lentivirus for 24 h on Day 7 in culture and examining the cells at Day 12 demonstrated
significant expression of HA-tagged APE1 in neurons but not in nonneuronal cells.
We also examined the expression of APE1 and HA-tagged WT-APE1, C65-APE1 (redox-
deficient/DNA repair-proficient) [17, 28] and 226/177-APE1(redox-proficient/repair-
deficient) [17] in the cultures we used in subsequent studies. For these studies, cells were
exposed to siRNAs for 48 h starting Day 3 in culture and to viral constructs for 2 days
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starting on Day 5 (Figure 4B). Experiments were performed on Day 13, and expression was
measured at the end of the experiments.
Neurons treated with the control virus containing the α CaM kinase II promoter and EGFP
demonstrated APE1 expression, but no HA-tagged protein was detected (Figure 4C).
However, APE1 expression increased with the APE1 constructs as it did in the HA-tagged
APE1 constructs (Figure 4C). As in previous studies, exposing cells to APE1siRNA reduced
APE1 expression; but the viral infection increased APE1 levels to control levels (Figure
4C). In cells treated with SCsiRNA, viral infection increased APE1 expression
approximately three-fold (Figure 4C).
We next determined whether overexpression of APE1 in sensory neurons was protective
when cultures were exposed to 10 Gy of radiation daily for three days and cell viability was
measured 24 h after the last dose. The cell viability of irradiated sensory neuronal cultures
treated with SCsiRNA and the lentiviral vector dropped to 71 ± 6 percent (Figure 5A). The
siRNA and viral treatments in the absence of radiation did not result in significant cell death.
Reducing APE1 expression with siRNA to 16 ± 4 % of controls (data not shown)
significantly reduced cell viability after radiation: from 97 ± 4% in cells not exposed to
radiation to 59 ± 4% in cells exposed to a dose of 10 Gy each day for 3 days (Figure 5B).
Overexpressing WT-APE1 in sensory neurons attenuated IR’s cytotoxic effects: cell
viability in neurons treated with SCsiRNA was 90 ± 4% (Figure 5A) and 87 ± 4 % in
neurons treated with APE1siRNA (Figure 5B).
Although these data indicate that overexpressing WT-APE1 specifically in sensory neurons
attenuates IR-induced cytotoxicity, the question remained whether the repair or redox
function of APE1 mediates the protective effects. To determine this, we selectively
overexpressed either the repair-competent APE1 mutation (C65-APE1) or the redox-
competent mutation (226+177-APE1), following the protocol shown in Figure 4B. In both
cases these mutations also had an HA tag to allow confirmation of over expression (see
Figure 4C). Overexpressing C65-APE1 in sensory neurons mimicked the effects we
observed with WT-APE1. With expression of the repair-competent mutation, viability in
cultures treated with SCsiRNA after three daily doses of 10 Gy was 88 ± 6% (Figure 5A),
whereas viability of cells treated with APE1siRNA was 83 ± 3% (Figure 5B). This compares
favorably to 71 ± 6 and a 59 ± 4% viability of cells in cultures treated with the lentiviral
vector and SCsiRNA or APE1siRNA, respectively. In neurons overexpressing 226+177-
APE1, radiation reduced cell viability of cultures treated with SCsiRNA to 68 ± 5% (Figure
5A). Cultures treated with APE1siRNA demonstrated 58 ± 3% viability (Figure 5B) which
was not significantly different from vector-treated cultures after exposure to IR. These
results strongly support the notion that APE1’s DNA repair component—not its redox
component—provides neuroprotection from IR.
3.5 Effect of APE1 on radiation-induced changes in release of iCGRP from sensory
neurons
To characterize the effects of IR and APE1 on an endpoint of sensory neuronal function, we
examined resting and capsaicin-evoked release of the neuropeptide CGRP. For these studies,
we initially determined the effects of exposing neuronal cultures to single or multiple doses
of 10 Gy of IR on the content and release of iCGRP. Figures 6A and 6B show that, 24 h
after exposing sensory neurons to either one or two once-daily doses of 10 Gy there was no
significant effect on resting or capsaicin-evoked iCGRP release (as measured in fmol
released/well of cells/10 min) or on the total content of CGRP in the cultures. In contrast,
exposing the cultures to 10 Gy/day for 3 or 4 days significantly reduced the capsaicin-
evoked iCGRP release (Figure 6A). In a similar manner, the total content of iCGRP was not
affected by up to 4 doses of 10 Gy given once per day (Figure 6B). Exposing cultures to 5
Vasko et al. Page 7
DNA Repair (Amst). Author manuscript; available in PMC 2012 September 5.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
doses considerably reduced iCGRP content. IR had no appreciable effect on resting release
of iCGRP from sensory neurons (Figure 6A). Based on these results and the fact that
multiple doses of radiation are used in therapy, we used 10 GY given daily for 3 days in
subsequent studies and examined release 24 h after the last dose.
Exposing sensory neurons that were pretreated with SCsiRNA (which did not reduce APE1
expression) and the lentiviral vector to 3 doses of 10 GY resulted in a significant reduction
in capsaicin-evoked release of iCGRP from 10.6 ± 0.5 % of total iCGRP content for controls
to 7.7 ± 0.4 % of total iCGRP content (figure 6C). This inhibition in release by IR is
analogous to that observed in untreated cells (figure 6A), indicating that SCsiRNA and
control viral infection do not affect iCGRP release. When cells were pretreated with
APE1siRNA which reduced the expression of APE1 by approximately 90%, IR significantly
reduced capsaicin-evoked release to 6.8 ± 0.5 % of total iCGRP content (figure 6C). We
next determined if increasing the expression of APE1 or APE1 mutants in sensory neurons
could reverse the effects of IR on iCGRP release. As in previous experiments, cultures were
first treated with siRNAs, infected with viral vectors using the neuronal specific promoter
∝CaM kinase II, then exposed to three doses of 10 Gy and release of iCGRP measured.
When cells treated with SCsiRNA or APE1siRNA were infected with the virus containing
WT-APE1 or the C65-APE1, the ability of IR to reduce capsaicin-evoked peptide release
was blocked. For example, in cells exposed to Ape1siRNA, viral vectors containing the WT-
APE1 or C65-APE1 constructs and radiation, the capsaicin-evoked release was 9.5 ± 0.8 and
10.4 ± 0.8 % of total content, respectively. In contrast, overexpressing the repair deficient/
redox competent mutant of APE1, 226+177A-APE1 had no effect on the ability of radiation
to reduce capsaicin-evoked release of iCGRP. In cells treated with SCsiRNA release was 7.8
± 0.3 % of total content (Figure 6C, left panel), while in cells exposed to APE1siRNA
release was 6.4 ± 0.4 % of total content (Figure 6B). Together the results support the notion
that the repair component of APE1 and not the redox function reverse the functional toxicity
produced by IR.
3.6 APX3330 affects IR-induced cell death and inhibition of iCGRP release
To substantiate that APE1’s redox function is not critical for protecting sensory neurons
from IR-induced toxicity, we determined how the APE1 redox-specific inhibitor APX3330
[25, 26, 35] affected radiation-induced neurotoxicity. APX3330 was added to the media 3
days prior to the first IR exposure and maintained throughout the 3 days of radiation
treatment (10 Gy/day). Cell viability or release studies were performed 24 h after the last
dose of radiation. Consistent with earlier studies (Figure 5) when neuronal cultures were
exposed to 3 doses of radiation, cell viability was significantly reduced, to 57 ± 2 % (Figure
7A). However, cultures treated with 10 μM APX3330 demonstrated cell viability of 81 ±
3%. Exposing cultures to 20 μM APX3330 effectively blocked IR’s effects. Neither
concentration of APX3330 had any effect on cell viability in cultures that were not exposed
to radiation.
Release studies also were performed 24 h after the last dose of radiation. As observed in
previous experiments, 3 doses of 10 Gy significantly reduced capsaicin-evoked iCGRP
release from 10.6 ± 0.3 % of total iCGRP content in the cultures to 7.1 ± 0.4 % of total
content (Figure 7B). Treating sensory neurons in culture with either 10 μM or 20 μM
APX3330 completely blocked the effects of radiation on peptide release but did not alter
capsaicin-evoked release in control cells (Figure 7B).
Because APX3330 reversed the neurotoxicity induced by IR, we asked whether the effect
would occur through blocking the redox actions of APE1. Based on the data above using
mutant APE1 constructs, it appears that the repair component of APE1 is critical for
neuroprotection. Thus, we tested whether APX3330 would be protective under conditions of
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reduced expression of native APE1 coupled with overexpression of the repair deficient/
redox competent mutant (266-177-APE1). In these experiments, exposing sensory neuronal
cultures to APE1siRNA caused an 84% reduction in native APE1 expression as indicated by
Western blotting (Figures 8C and 8D), whereas viral infection with the 266-177-APE1
construct results in expression of this mutant (Figures 8C and 8D). In these cultures, we
treated cells with 20 μM APX3330 for 3 days prior to the first IR exposure and throughout
the 3 days of radiation treatment (10 Gy/day). In contrast to the neuroprotective effects of
APX3330 in sensory neurons with native APE1 (see Figure 7), the compound was not
effective in cultures overexpressing the APE1 mutant 226-177. As observed in previous
experiments, exposing cultures to 10 GY of radiation per day for three days resulted in 75 ±
1 % viability in control cells, 56 ± 4 % in cells with APE1 knock-down and 53 ± 3 % in
cells with APE1 knock-down and overexpression of 226-177-APE1. Viability after
APX3330 was 51 ± 3 % (Figure 8A). In a similar manner, IR reduced the evoked release of
iCGRP from 10.7 ± 0.5 % of total peptide content to 7.5 ± 0.4 % of total content (Figure
8B). With APE1 knock-down and 266-177 overexpression release was 5.6 ± 0.2 % of total
content in the absence of APX3330 and 5.9 ± 0.5 % with APX3330 treatment. As a positive
control for these experiments, we examined whether APX3330 was neurorprotective to
neuronal cultures exposed to SCsiRNA. In neuronal cultures treated with SCsiRNA, 20 μM
APX3330 did not result in a significant change in cell viability (as measured by trypan blue
exclusion) or in the capsaicin-evoked release of ICGRP (Table 1). Exposing cultures treated
with SCsiRNA to 10 Gy of radiation for 3 consecutive days resulted in a significant loss in
cell viability and a decrease in evoked release of iCGRP as was observed in other
experiments. In these cells, the radiation-induced neurotoxicity was blocked by treating
cultures with 20 μM APX3330 (Table 1) in a manner analogous to cultures not exposed to
siRNA (see Figure 7). Taken together, these results show that in the presence of APE1 that
has only redox activity APX3330 is not neuroprotective, whereas in cells with intact APE1,
the drug attenuates radiation-induced toxicity. These data support the notion that the APE1
repair function is a necessary component in the neuroprotective actions of APX3330.
4. Discussion
The data presented here establish that APE1 is neuroprotective for IR-induced damage.
Using cultures of adult hippocampal and sensory neurons, we confirm previous work
showing that exposing cells to increasing doses of IR increases cell death, which correlates
with DNA damage [13, 14, 16, 36]. We also demonstrate for the first time that radiation
reduces capsaicin-evoked CGRP release from sensory neurons, suggesting reduced sensory
neuron function. Reducing APE1 expression in hippocampal and sensory neuronal cultures
using siRNA augments IR-induced cell death, double strand breaks (indicated by increased
histone 2AX phosphorylation) [32], and inhibition of transmitter release. In contrast,
overexpression of APE1 in cells with depleted or “normal” APE1 levels (those treated with
SCsiRNA) blocks IR’s adverse effects on all three endpoints.
We initially used a CMV promoter to overexpress APE1, and those experiments
demonstrated that overexpression confers neuroprotection in hippocampal and sensory
neuronal cultures. The question remains whether the protective effects of APE1 are
occurring in neurons or in non-neuronal cells present in primary cultures. This issue is
significant because IR could directly damage neurons or cause secondary effects to support
cells [2, 7, 37]. For example, IR increases cytokine production in glial cells, which
influences neuronal function. To answer this question, we developed lentiviral constructs
that contained the neuronal-specific promoter for α CaM kinase II and overexpressed APE1
and modified APE1 mutant proteins [33]. Use of this promoter resulted in selective APE1
expression in cultured neurons and the level of APE1 expression in cells infected with the
virus was similar to that observed in non-treated cells. Of importance, overexpression of
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APE1 in neurons attenuated radiation-induced neurotoxicity, strongly supporting the notion
that IR damage occurs directly to the neurons.
APE1’s multifunctionality has long been appreciated. It is involved in repairing oxidative
damage to DNA, as can occur from IR [38]. APE1 also is a redox co-activator of many
transcription factors [18–20]. The repair and redox activities of APE1 are located in two
functionally distinct regions within the protein [18, 19, 39]. By selectively overexpressing
one of these functions in mutated APE1 molecules, we address the question of whether
APE1’s repair, redox or combined functions are critical for neuroprotection. Cys65
mutations remove the redox function of APE1 but do not affect the repair function [19, 39–
41], whereas mutation of a variety of amino acids (e.g., Arg 177 and Asn 226) eliminates the
repair function but leaves the redox function intact [42]. Overexpressing the redox-deficient
Cys65 mutation of APE1 in sensory neurons reverses IR’s toxic effects in a manner
analogous to that seen with WT-APE1. However, overexpressing the repair-deficient
mutation is not neuroprotective. These results demonstrate that only APE1’s DNA repair
function is essential for post-mitotic neuronal cell survival and function after exposure to
oxidative damage [17, 29].
Of interest, an APE1 redox-specific inhibitor, APX3330, also protected neuronal cells from
IR-induced cell death and the deleterious effects of iCGRP release inhibition. We previously
had determined that APE1 can exist in an unfolded form [41]. We also demonstrated that 1)
APX3330 binds to partially unfolded APE1, 2) the partially or locally unfolded form is the
redox-active form [41] existing in equilibrium with the fully folded state, and 3) APX3330
can perturb this equilibrium, trapping a partially unfolded state of APE1 [41]. Thus, in using
APX3330 to block APE1’s redox function, APE1’s repair function is fully expressed,
leading to the protective effects shown in Figure 6. The results with APX3330 parallel those
using the C65A APE1 mutant, in that blocking APE1’s redox function still allows for
neuronal protection. This “trapped” APE1 could also have a reduced affinity for other
proteins with which APE1 interacts—allowing its repair function to dominate [19, 43, 44].
This possibility is further supported by the fact that APX3330 is not neuroprotective in
neurons expressing the redox competent APE1 mutant, but only when native APE1 is
expressed.
We assessed three endpoints to determine whether reducing APE1 expression increases IR-
induced neurotoxicity. Our cell viability studies show that dose-dependent cell death is
greater in neuronal cultures with reduced APE1 expression 24 h after IR treatment.
Overexpressing APE1 significantly reduced cell death in neuronal cultures. This confirms
previous work demonstrating that in situ or in vitro exposure to radiation triggers neuronal
apoptosis [13, 15] and supports the idea that the cell death is secondary to DNA damage,
which is our second endpoint. We also show significant DNA damage within 1 h of
radiation treatment, evidenced by substantially increased H2A.X phosphorylation. Findings
for DNA damage parallel cell viability: both increase significantly in cultures with reduced
APE1 expression and both were decreased significantly by APE1 overexpression.
We measured the resting and capsaicin-evoked release of the neuropeptide CGRP as our
third endpoint. Increasing the number of exposures of sensory neurons to 10 Gy of radiation
reduces the capsaicin-evoked release of CGRP without altering its resting release.
Interestingly, the total CGRP content in the cultures is not reduced until 5 doses of 10 Gy
are delivered, suggesting that the cumulative amount causes loss of CGRP-containing
neurons or decreases peptide expression. The reduction in radiation-induced release is more
pronounced in cultures with reduced APE1 expression and is reversed by APE1
overexpression.
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A major neurological side effect of IR is loss of cognitive function; [7] this correlates with
decreased hippocampal neurogenesis [4, 5]. Although numerous interventions have been
proposed to minimize the cognitive side effects of IR, to date none have proven effective.
Our results suggest that radiation can affect adult hippocampal neurons, and that augmenting
APE1’s repair function largely reverses the toxic effects. Additionally, because APX3330’s
redox inhibition of APE1 is neuroprotective for sensory neurons after IR exposure, further
studies are warranted to determine if this compound can minimize IR’s effect of cognitive
dysfunction. This is an intriguing novel finding because previous studies demonstrated
APX3330’s cytostatic effect on cancer cells [25, 26, 45, 46].
Although peripheral neuropathy is not considered a major side effect of IR, its effects on
small-diameter sensory neurons could have important clinical ramifications. Numerous
studies suggest that small-diameter sensory neurons contribute to neurogenic inflammation
[47, 48] and wound healing [49, 50]. Not surprisingly, studies show that toxic effects of
radiation on the GI tract alter the neuropeptides SP and CGRP, which small-diameter
sensory neurons synthesize and release [10, 11]. Indeed, ablation of capsaicin-sensitive
small-diameter sensory neurons and CGRP receptor antagonists increases the severity of IR-
induced damage to the gut [12]. Because IR decreases CGRP release in isolated sensory
neurons, this effect could contribute to IR-induced tissue damage.
5. Conclusion
In conclusion, we demonstrate here that APE1’s repair function is required for protection of
hippocampal and DRG neuronal cultures, while APE1’s redox activity does not appear to be
involved in neuronal function or survival. Because APX3330 also demonstrates neuronal
protection from IR, these studies form the foundation for additional studies in vivo to
ascertain APX3330’s protective effect and the role of APE1’s repair component in reversing
neurocognitive impairment and peripheral neuropathy following IR treatment.
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APE1 human apurinic/apyrimidinic (AP) endonuclease
BER base excision repair
CGRP calcitonin gene-related peptide
CMV cytomegalovirus
CNS central nervous system
DRG dorsal root ganglion
EGFP enhanced green fluorescent protein
HA hemagglutinin antibodies
iCGRP immunoreactive calcitonin gene-related peptide
IR ionizing radiation
IRES internal ribosome entry site
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Ref-1 redox effector factor 1
ROS reactive oxygen species
SCsiRNA scramble siRNA
SP (neuropeptide) substance P
WT-APE1 wild type APE1
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Figure 1. Reducing APE1 expression decreases cell viability in sensory neuronal and
hippocampal cultures after IR; APE1 overexpression is protective
A and B: Each point represents the mean % of cells surviving 24 h after exposure to IR as
measured by trypan blue exclusion. Sensory neuronal cultures (A) or hippocampal cultures
(B) were treated with medium alone (open squares), SCsiRNA (closed triangles),
APE1siRNA (closed inverted triangles); then adenovirus containing the WT-APE1 construct
(closed circles), or APE1siRNA then adenovirus containing the WT-APE1 construct (closed
squares) as discussed in Methods. C: Representative Western blots showing APE1 and actin
from cultures exposed to either SCsiRNA or APE1siRNA as indicated. D: The ordinate
represents the density of APE1 bands from Western blots normalized to actin. Each column
represents the mean ± SEM from 3 separate harvests of cells used in the experiments in the
top figures and exposed to either SCsiRNA or APE1siRNA as indicated. An asterisk
indicates a statistically significant reduction in Ape1 expression compared to values
obtained on cultures exposed to SCsiRNA.
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Figure 2. IR-induced H2A.X phosphorylation in cultured sensory neurons is augmented by
reduced APE1 expression and blocked by APE1 overexpression
A: Representative Western blots showing phospho-H2A.X and actin from cultures prior to
30 Gy of IR and 30 and 60 min afterward. Cultures were exposed to either SCsiRNA or
APE1siRNA alone (top panel), siRNAs then the viral vector (middle panel), or siRNAs then
Ad5 for WT APE1 (bottom panel). B: Densitometry of phospho-H2A.X expression
normalized to actin from 3 independent experiments. Columns represent the mean ± SEM
from cultures treated with SCsiRNA (open columns) or APE1siRNA (closed columns), with
or without viral infection, as indicated 30 or 60 min after 30 Gy of IR.
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Figure 3. IR-induced H2A.X phosphorylation in cultures of hippocampal neurons is augmented
by reduced APE1 expression and blocked by APE1 overexpression
A: Representative Western blots showing phospho-H2A.X and actin from cultures prior to
15 Gy of IR and 30 and 60 min afterward. Cultures were exposed to either SCsiRNA or
APE1siRNA alone (top panel), siRNAs then the viral vector (middle panel), or siRNAs then
Ad5 for WT APE1 (bottom panel). B: Densitometric results of phospho-H2A.X expression,
normalized to actin (3 independent experiments). Columns represent the mean ± SEM from
cultures treated with SCsiRNA (open columns) or APE1siRNA (closed columns), with or
without viral infection, as indicated 30 or 60 min after 15 Gy of IR.
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Figure 4. Expression of APE1 and APE1 mutants in sensory neurons using lentivirus with the α
CaM kinase II promoter
A: Representative micrographs showing that expression of HA-tagged WT APE1 is
restricted to sensory neurons 4 days after exposure to 150pfu/cell of lentivirus containing the
α CaM kinase II promoter, HA-tagged WT-APE1, IRES, and EGFP. Top left panel: bright-
field image. Top right panel: red staining for peripherin. Bottom left panel: green staining
for the HA tag. Bottom right panel: co-localization of peripherin and HA, indicated by
yellow color. B: Time line for experiments using siRNAs and lentiviral infection. C: Top
portion: representative Western blots demonstrating APE1 expression, HA-tagged WT
APE1, and APE1 mutants in cultures used in experiments illustrated in Figures 5 and 7.
Cultures were exposed to either SCsiRNA or APE1siRNA, then to lentiviral constructs as
indicated. Lower portion: bar graph summarizes the effects of various treatments to decrease
or increase APE1 expression. Densitometric results from 3 independent experiments,
normalized to actin. Columns represent the mean ± SEM from cultures treated with
SCsiRNA (open columns) or APE1siRNA (shaded columns) with viral infection as
indicated.
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Figure 5. Overexpression of WT-APE1 and the redox mutant APE1 (C65), but not the repair
mutant APE1 (226+177), attenuate radiation-induced cell death
Columns represent the mean ± SEM of the % cells surviving 24 h after exposure to 3 doses
of IR (10 Gy/dose) as measured by trypan blue exclusion. Sensory neuronal cultures were
treated with SCsiRNA (A) or APE1siRNA (B) and viral constructs containing the α CaM
kinase II promoter as indicated. Horizontal bars represent cells exposed to IR.
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Figure 6. Overexpression of WT-APE1 and the redox mutant APE1 (C65), but not the repair
mutant APE1 (226+177) attenuates radiation-induced decreases in iCGRP release from sensory
neurons
A: Columns represent the mean ± SEM of iCGRP release in fmol/well/min for sensory
neurons in culture, either not exposed to radiation or exposed to 10 Gy/day for 1 to 5 days.
Twenty-four hours after the last IR dose, wells of cells were exposed for 10 min to HEPES
alone (basal; open columns), or HEPES in the presence of 30 nM capsaicin (solid columns).
B: Columns represent the mean ± SEM of iCGRP content in fmol/well for sensory neurons
in culture from the release experiments in Figure A. C: Columns are the mean ± SEM of the
release of iCGRP evoked by 30 nM capsaicin as the % of total iCGRP content over a 10-min
period. Open columns are cultures not exposed to ionizing radiation; filled columns are cells
exposed to 10 Gy/day for 3 days. Cultures were treated with SCsiRNA (left panel) or
APE1siRNA (right panel) and viral constructs.
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Figure 7. APX3330 attenuates IR-induced cell death and decreases in iCGRP release from
sensory neurons
A: Columns represent the mean ± SEM of % cells surviving 24 h with no exposure to
radiation (open columns) or after exposure to 3 doses of 10 Gy of IR (shaded columns) as
measured by trypan blue exclusion. B: Columns show the mean ± SEM of the release of
iCGRP evoked by 30 nM capsaicin as the % of total iCGRP content over a 10-min period.
Open columns are cultures not exposed to IR; filled columns are cells exposed to 10 Gy/day
for 3 days. Cultures were treated with APX3330 as indicated for three days before and
throughout IR exposure.
Vasko et al. Page 21
DNA Repair (Amst). Author manuscript; available in PMC 2012 September 5.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 8. APX3330 does not attenuate IR-induced cell death and decreases in iCGRP release
from sensory neurons expressing the redox competent APE1 mutant
A: Columns represent the mean ± SEM of % cells surviving 24 h after no exposure to
radiation (open columns) or after exposure to 3 doses of 10 Gy of IR (shaded columns).
Cultures were treated with siRNA, lentivirus, and/or APX3330 as indicated. B: Columns
show the mean ± SEM of the release of iCGRP evoked by 30 nM capsaicin as the % of total
iCGRP content over a 10-min period. Open columns are cultures not exposed to IR; filled
columns are cells exposed to 10 Gy/day for 3 days. Cultures were treated with siRNA,
lentivirus, and/or APX3330 as indicated. C: A representative Western blot showing APE1
HA-tagged 266-177-APE1 and actin from cultures exposed to either SCsiRNA or
APE1siRNA or virus as indicated. D: The ordinate represents the density of APE1 bands
from Western blots normalized to actin. Each column represents the mean ± SEM from 3
separate harvests of cells used in the experiments in the top figures and exposed to either
SCsiRNA, APE1siRNA and/or virus as indicated. An asterisk indicates a statistically
significant reduction in APE1 expression compared to values obtained on cultures exposed
to SCsiRNA.
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Table 1
Effect of APX3330 on ionizing radiation-induced cell death and decrease in iCGRP release in sensory neurons
treated with scramble siRNA
Treatment n Percent Survival
CAP Evoked Release of iCGRP (% of Total
Content)
SCsiRNA (100nM) 9 94 ± 2 10.2 ± 0.31
SCsiRNA (100nM) + APX3330 (20 μM) 9 97 ± 2 10.2 ± 0.27
SCsiRNA (100nM) + 10Gy/dose × 3 9 76 ± 4* 7.9 ± 0.28*
SCsiRNA (100nM) + 10Gy/dose × 3 + APX3330 (20 μM) 9 93 ± 6+ 9.6 ± 0.25+
Data are presented as mean ± S.E.M. An asterisk indicated a significant different (p< .05) compared to SCsiRNA without IR, whereas a + indicates
a significant difference between cells in the absence or presence of APX3330 treatment
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